1,286
Views
78
CrossRef citations to date
0
Altmetric
Original

The role of dopamine for the pathophysiology of schizophrenia

, , &
Pages 337-345 | Published online: 11 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Özge Küçükerdönmez, Murat Urhan, Merve Altın, Özge Hacıraifoğlu & Burak Yıldız. (2019) Assessment of the relationship between food addiction and nutritional status in schizophrenic patients. Nutritional Neuroscience 22:6, pages 392-400.
Read now
Louise K. Hoeffding, Linh T.T. Duong, Andrés Ingason, Anders Rosengren, Ester Sorbanski, Stephanie H. Witt, Srdjan Djurovic, Ole A. Andreassen, Thomas Hansen, Thomas Werge & Henrik B. Rasmussen. (2016) Identification of rare high-risk copy number variants affecting the dopamine transporter gene in mental disorders. Nordic Journal of Psychiatry 70:4, pages 276-279.
Read now
Ami Citri & Sabina Berretta. (2016) Claustral Delusions. Claustrum 1:1.
Read now

Articles from other publishers (75)

F. Krohn, E. Lancini, M. Ludwig, M. Leiman, G. Guruprasath, L. Haag, J. Panczyszyn, E. Düzel, D. Hämmerer & M. Betts. (2023) Noradrenergic neuromodulation in ageing and disease. Neuroscience & Biobehavioral Reviews 152, pages 105311.
Crossref
Vuslat B. Juska, Graeme Maxwell, Pedro Estrela, Martyn E. Pemble & Alan O'Riordan. (2023) Silicon microfabrication technologies for biology integrated advance devices and interfaces. Biosensors and Bioelectronics, pages 115503.
Crossref
Porkodi Ayyar & Jamuna Rani Ravinder. (2022) Animal models for the evaluation of antipsychotic agents. Fundamental & Clinical Pharmacology 37:3, pages 447-460.
Crossref
Vahulabaranan Rajagopalan, Swethaa Venkataraman, Devi Sri Rajendran, Vaidyanathan Vinoth Kumar, Vaithyanathan Vasanth Kumar & Gayathri Rangasamy. (2023) Acetylcholinesterase biosensors for electrochemical detection of neurotoxic pesticides and acetylcholine neurotransmitter: A literature review. Environmental Research 227, pages 115724.
Crossref
Wei-Hsin ChenWenting WangQianqi LinDavid-Benjamin Grys, Marika Niihori, Junyang HuangShu HuBart de Nijs, Oren A. Scherman & Jeremy J. Baumberg. (2022) Plasmonic Sensing Assay for Long-Term Monitoring (PSALM) of Neurotransmitters in Urine. ACS Nanoscience Au 3:2, pages 161-171.
Crossref
Seongtak Kang, Jeongrak Park, Yunho Jeong, Yong-Seok Oh & Ji-Woong Choi. (2022) Second-Derivative-Based Background Drift Removal for a Tonic Dopamine Measurement in Fast-Scan Cyclic Voltammetry. Analytical Chemistry 94:33, pages 11459-11463.
Crossref
Abhinanda Chowdhury & Prashant Chandra Singh. (2022) Role of the weak noncovalent interactions in the stability of the aggregated protonated dopamine in the aqueous solution: spectroscopic and quantum chemical calculation studies. Journal of Chemical Sciences 134:1.
Crossref
Burak Yaman. 2022. Parkinson’s Disease - Animal Models, Current Therapies and Clinical Trials [Working Title]. Parkinson’s Disease - Animal Models, Current Therapies and Clinical Trials [Working Title].
Burak Yaman. 2022. Parkinson’s Disease - Animal Models, Current Therapies and Clinical Trials [Working Title]. Parkinson’s Disease - Animal Models, Current Therapies and Clinical Trials [Working Title].
Jenny I Aguilar, Mary Hongying Cheng, Josep Font, Alexandra C Schwartz, Kaitlyn Ledwitch, Amanda Duran, Samuel J Mabry, Andrea N Belovich, Yanqi Zhu, Angela M Carter, Lei Shi, Manju A Kurian, Cristina Fenollar-Ferrer, Jens Meiler, Renae Monique Ryan, Hassane S Mchaourab, Ivet Bahar, Heinrich JG Matthies & Aurelio Galli. (2021) Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia. eLife 10.
Crossref
Matthew Williams. 2021. The Neuropathology of Schizophrenia. The Neuropathology of Schizophrenia 141 165 .
Zongya Zhao, Chang Wang, Qingli Yuan, Junqiang Zhao, Qiongqiong Ren, Yongtao Xu, Jie Li & Yi Yu. (2020) Dynamic changes of brain networks during feedback-related processing of reinforcement learning in schizophrenia. Brain Research 1746, pages 146979.
Crossref
Eid Abohamza, Thomas Weickert, Manal Ali & Ahmed A. Moustafa. (2020) Reward and punishment learning in schizophrenia and bipolar disorder. Behavioural Brain Research 381, pages 112298.
Crossref
Shimwe Dominique Niyonambaza, Praveen Kumar, Paul Xing, Jessy Mathault, Paul De Koninck, Elodie Boisselier, Mounir Boukadoum & Amine Miled. (2019) A Review of Neurotransmitters Sensing Methods for Neuro-Engineering Research. Applied Sciences 9:21, pages 4719.
Crossref
Samantha E. Yohn & P. Jeffrey Conn. (2018) Positive allosteric modulation of M 1 and M 4 muscarinic receptors as potential therapeutic treatments for schizophrenia. Neuropharmacology 136, pages 438-448.
Crossref
Iris E. Sommer, Hidde Kleijer & Kenneth Hugdahl. (2018) Toward personalized treatment of hallucinations. Current Opinion in Psychiatry 31:3, pages 237-245.
Crossref
Amanda M. Duran & Jens Meiler. (2017) Computational design of membrane proteins using RosettaMembrane. Protein Science 27:1, pages 341-355.
Crossref
Sarah Eisenacher & Mathias Zink. (2017) The Importance of Metamemory Functioning to the Pathogenesis of Psychosis. Frontiers in Psychology 8.
Crossref
Ahmed A. Moustafa, Julia K. Garami, Justin Mahlberg, Jan Golembieski, Szabolcs Keri, BlaŻej Misiak & Dorota Frydecka. (2016) Cognitive function in schizophrenia: conflicting findings and future directions. Reviews in the Neurosciences 27:4, pages 435-448.
Crossref
Rodrigo Moraga-Amaro, Hugo González, Valentina Ugalde, Juan Pablo Donoso-Ramos, Daisy Quintana-Donoso, Marcelo Lara, Bernardo Morales, Patricio Rojas, Rodrigo Pacheco & Jimmy Stehberg. (2016) Dopamine receptor D5 deficiency results in a selective reduction of hippocampal NMDA receptor subunit NR2B expression and impaired memory. Neuropharmacology 103, pages 222-235.
Crossref
Rachel J. Sizemore, Rong Zhang, Naili Lin, Liping Goddard, Timothy Wastney, Louise C. Parr-Brownlie, John N.J. Reynolds & Dorothy E. Oorschot. (2016) Marked differences in the number and type of synapses innervating the somata and primary dendrites of midbrain dopaminergic neurons, striatal cholinergic interneurons, and striatal spiny projection neurons in the rat. Journal of Comparative Neurology 524:5, pages 1062-1080.
Crossref
Y. Ayhan, C.E. Terrillion & M.V. Pletnikov. 2016. The Neurobiology of Schizophrenia. The Neurobiology of Schizophrenia 353 381 .
Toshikazu Ikuta, Pamela DeRosse, Miklos Argyelan, Katherine H. Karlsgodt, Peter B. Kingsley, Philip R. Szeszko & Anil K. Malhotra. (2015) Subcortical modulation in auditory processing and auditory hallucinations. Behavioural Brain Research 295, pages 78-81.
Crossref
Beryl Luk, Mohinuddin Mohammed, Fang Liu & Frank J. S. Lee. (2015) A Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine Reuptake. PLOS ONE 10:8, pages e0136641.
Crossref
Vaibhav A. Diwadkar, Ashley Burgess, Ella Hong, Carrie Rix, Paul D. Arnold, Gregory L. Hanna & David R. Rosenberg. (2015) Dysfunctional Activation and Brain Network Profiles in Youth with Obsessive-Compulsive Disorder: A Focus on the Dorsal Anterior Cingulate during Working Memory. Frontiers in Human Neuroscience 9.
Crossref
Tae Jung Kim, Tae Jun Kim, Hyon Lee, Young Eun Kim & Beom S. Jeon. (2014) A case of Parkin disease (PARK2) with schizophrenia: Evidence of regional selectivity. Clinical Neurology and Neurosurgery 126, pages 35-37.
Crossref
Pamela F. Marcott, Aphroditi A. Mamaligas & Christopher P. Ford. (2014) Phasic Dopamine Release Drives Rapid Activation of Striatal D2-Receptors. Neuron 84:1, pages 164-176.
Crossref
Sofya Abazyan & Mikhail V. Pletnikov. 2014. Behavioral Genetics of the Mouse. Behavioral Genetics of the Mouse 189 207 .
. 2014. Behavioral Genetics of the Mouse. Behavioral Genetics of the Mouse 86 239 .
I. Bonoldi & O. D. Howes. (2014) Presynaptic Dopaminergic Function: Implications for Understanding Treatment Response in Psychosis. CNS Drugs 28:7, pages 649-663.
Crossref
Hideo Tsukada, Hiroyuki Ohba, Masakatsu Kanazawa, Takeharu Kakiuchi & Norihiro Harada. (2013) Evaluation of 18F-BCPP-EF for mitochondrial complex 1 imaging in the brain of conscious monkeys using PET. European Journal of Nuclear Medicine and Molecular Imaging 41:4, pages 755-763.
Crossref
Michael A.P. Bloomfield, Celia J.A. Morgan, Alice Egerton, Shitij Kapur, H. Valerie Curran & Oliver D. Howes. (2014) Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms. Biological Psychiatry 75:6, pages 470-478.
Crossref
Toshikazu Ikuta, Delbert G. Robinson, Juan A. Gallego, Bart D. Peters, Patricia Gruner, John Kane, Majnu John, Serge Sevy, Anil K. Malhotra & Philip R. Szeszko. (2014) Subcortical modulation of attentional control by second-generation antipsychotics in first-episode psychosis. Psychiatry Research: Neuroimaging 221:2, pages 127-134.
Crossref
Oliver D. Howes, Matthew Williams, Kemal Ibrahim, Garret Leung, Alice Egerton, Philip K. McGuire & Federico Turkheimer. (2013) Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. Brain 136:11, pages 3242-3251.
Crossref
Marylène C. Focant & Emmanuel Hermans. (2013) Protein interacting with C kinase and neurological disorders. Synapse 67:8, pages 532-540.
Crossref
Oliver D. Howes, Paul Shotbolt, Michael Bloomfield, Kirstin Daalman, Arsime Demjaha, Kelly M. J. Diederen, Kemal Ibrahim, Euitae Kim, Philip McGuire, René S. Kahn & Iris E. Sommer. (2013) Dopaminergic Function in the Psychosis Spectrum: An [18F]-DOPA Imaging Study in Healthy Individuals With Auditory Hallucinations. Schizophrenia Bulletin 39:4, pages 807-814.
Crossref
Stefan Brauns, Randy L. Gollub, Esther Walton, Johanna Hass, Michael N. Smolka, Tonya White, Thomas H. Wassink, Vince D. Calhoun & Stefan Ehrlich. (2013) Genetic variation in GAD1 is associated with cortical thickness in the parahippocampal gyrus. Journal of Psychiatric Research 47:7, pages 872-879.
Crossref
Georgia Rentesi, Katerina Antoniou, Marios Marselos, Marika Syrrou, Zeta Papadopoulou-Daifoti & Maria Konstandi. (2013) Early maternal deprivation-induced modifications in the neurobiological, neurochemical and behavioral profile of adult rats. Behavioural Brain Research 244, pages 29-37.
Crossref
Meina Quan, Sang-Hyuk Lee, Marek Kubicki, Zora Kikinis, Yogesh Rathi, Larry J. Seidman, Raquelle I. Mesholam-Gately, Jill M. Goldstein, Robert W. McCarley, Martha E. Shenton & James J. Levitt. (2013) White matter tract abnormalities between rostral middle frontal gyrus, inferior frontal gyrus and striatum in first-episode schizophrenia. Schizophrenia Research 145:1-3, pages 1-10.
Crossref
S. Trost, B. Platz, J. Usher, H. Scherk, T. Wobrock, S. Ekawardhani, J. Meyer, W. Reith, P. Falkai & O. Gruber. (2012) The DTNBP1 (dysbindin-1) gene variant rs2619522 is associated with variation of hippocampal and prefrontal grey matter volumes in humans. European Archives of Psychiatry and Clinical Neuroscience 263:1, pages 53-63.
Crossref
Paolo Fusar-Poli & Andreas Meyer-Lindenberg. (2013) Striatal Presynaptic Dopamine in Schizophrenia, Part I: Meta-Analysis of Dopamine Active Transporter (DAT) Density. Schizophrenia Bulletin 39:1, pages 22-32.
Crossref
C. Christoph Schultz, Paolo Fusar-Poli, Gerd Wagner, Kathrin Koch, Claudia Schachtzabel, Oliver Gruber, Heinrich Sauer & Ralf G. M. Schlösser. (2012) Multimodal functional and structural imaging investigations in psychosis research. European Archives of Psychiatry and Clinical Neuroscience 262:S2, pages 97-106.
Crossref
Nicholas A. Courtney, Aphroditi A. Mamaligas & Christopher P. Ford. (2012) Species Differences in Somatodendritic Dopamine Transmission Determine D2-Autoreceptor-Mediated Inhibition of Ventral Tegmental Area Neuron Firing. The Journal of Neuroscience 32:39, pages 13520-13528.
Crossref
Wei Song, Hillel Zukor, Shih-Hsiung Lin, Jacob Hascalovici, Adrienne Liberman, Ayda Tavitian, Jeannie Mui, Hojatollah Vali, Xin-Kang Tong, Sanjeev K. Bhardwaj, Lalit K. Srivastava, Edith Hamel & Hyman M. Schipper. (2012) Schizophrenia-Like Features in Transgenic Mice Overexpressing Human HO-1 in the Astrocytic Compartment. The Journal of Neuroscience 32:32, pages 10841-10853.
Crossref
K O Schubert, M Föcking, J H M Prehn & D R Cotter. (2011) Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?. Molecular Psychiatry 17:7, pages 669-681.
Crossref
Paolo Fusar-Poli & A. Meyer-Lindenberg. (2012) Presynaptic dopamine alterations in schizophrenia: Functional or structural defect?. Psychiatry Research: Neuroimaging 202:3, pages 271-272.
Crossref
Mounir H. Fawzi & Mohab M. Fawzi. (2012) Disordered eating attitudes in Egyptian antipsychotic naive patients with schizophrenia. Comprehensive Psychiatry 53:3, pages 259-268.
Crossref
Hugo Lövheim. (2012) A new three-dimensional model for emotions and monoamine neurotransmitters. Medical Hypotheses 78:2, pages 341-348.
Crossref
Michy P KellyNicholas J Brandon. (2011) Taking a bird’s eye view on a mouse model review: a comparison of findings from mouse models targeting DISC1 or DISC1 -interacting proteins . Future Neurology 6:5, pages 661-677.
Crossref
O Howes, S Bose, F Turkheimer, I Valli, A Egerton, D Stahl, L Valmaggia, P Allen, R Murray & P McGuire. (2011) Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Molecular Psychiatry 16:9, pages 885-886.
Crossref
P Fusar-Poli, O D Howes, P Allen, M Broome, I Valli, M-C Asselin, A J Montgomery, P M Grasby & P McGuire. (2009) Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Molecular Psychiatry 16:1, pages 67-75.
Crossref
V. E. Golimbet, I. S. Lebedeva, M. V. Monakhov, G. I. Korovaitseva, T. V. Lezheiko, L. I. Abramova, V. G. Kaleda & V. L. Karpov. (2010) The Cys allele (the Ser311Cys polymorphism) of the dopamine d2 receptor is associated with schizophrenia and impairments to selective attention in patients. Neuroscience and Behavioral Physiology 41:1, pages 22-25.
Crossref
Stefan C. Dombrowski, Karen L. Gischlar & Martin MrazikStefan C. Dombrowski, Karen L. Gischlar & Martin Mrazik. 2011. Assessing and Treating Low Incidence/High Severity Psychological Disorders of Childhood. Assessing and Treating Low Incidence/High Severity Psychological Disorders of Childhood 199 221 .
Trevor Archer, Richard J. Beninger, Tomas Palomo & Richard M. Kostrzewa. (2010) Epigenetics and Biomarkers in the Staging of Neuropsychiatric Disorders. Neurotoxicity Research 18:3-4, pages 347-366.
Crossref
Christopher P. Ford, Stephanie C. Gantz, Paul E. M. Phillips & John T. Williams. (2010) Control of Extracellular Dopamine at Dendrite and Axon Terminals. The Journal of Neuroscience 30:20, pages 6975-6983.
Crossref
Jana Strohmaier, Josef Frank, Jens R. Wendland, Johannes Schumacher, Rami Abou Jamra, Jens Treutlein, Vanessa Nieratschker, René Breuer, Manuel Mattheisen, Stefan Herms, Thomas W. Mühleisen, Wolfgang Maier, Markus M. Nöthen, Sven Cichon, Marcella Rietschel & Thomas G. Schulze. (2010) A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case–control and family-based sample of German ancestry. Schizophrenia Research 118:1-3, pages 98-105.
Crossref
Felice Iasevoli, Germano Fiore, Maria Cicale, Giovanni Muscettola & Andrea de Bartolomeis. (2010) Haloperidol induces higher Homer1a expression than risperidone, olanzapine and sulpiride in striatal sub-regions. Psychiatry Research 177:1-2, pages 255-260.
Crossref
Kathrin Koch, Claudia Schachtzabel, Gerd Wagner, Julia Schikora, Christoph Schultz, Jürgen R. Reichenbach, Heinrich Sauer & Ralf G.M. Schlösser. (2010) Altered activation in association with reward-related trial-and-error learning in patients with schizophrenia. NeuroImage 50:1, pages 223-232.
Crossref
Audrey Baguelin-Pinaud, Sylvie Robert, Jean-François Ménard & Florence Thibaut. (2010) Prenatal exposure to tobacco and risk for schizophrenia: a retrospective epidemiological study. Comprehensive Psychiatry 51:2, pages 106-109.
Crossref
Rana El-Rawas, Nayef E. Saadé, Nathalie Thiriet, Samir Atweh, Mohamed Jaber & Hassen A. Al-Amin. (2009) Developmental changes in the mRNA expression of neuropeptides and dopamine and glutamate receptors in neonates and adult rats after ventral hippocampal lesion. Schizophrenia Research 113:2-3, pages 298-307.
Crossref
Gerhard Rammes, Christine Hosp, Brigitte Eisensamer, Sascha Tanasic, Caroline Nothdurfter, Walter Zieglgänsberger & Rainer Rupprecht. (2009) Identification of a Domain which Affects Kinetics and Antagonistic Potency of Clozapine at 5-HT3 Receptors. PLoS ONE 4:8, pages e6715.
Crossref
Larissa de Oliveira, Cecília Marly dos S. Spiazzi, Thaize Bortolin, Leila Canever, Fabricia Petronilho, Franciele Gonçalves Mina, Felipe Dal-Pizzol, João Quevedo & Alexandra I. Zugno. (2009) Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 33:6, pages 1003-1008.
Crossref
Frank J.S. Lee, Lin Pei & Fang Liu. (2009) Disruption of the dopamine transporter–dopamine D2 receptor interaction in schizophrenia. Synapse 63:8, pages 710-712.
Crossref
Ralf Brisch, Hans-Gert Bernstein, Dieter Krell, Henrik Dobrowolny, Hendrik Bielau, Johann Steiner, Tomasz Gos, Sieglinde Funke, Renate Stauch, Sven Knüppel & Bernhard Bogerts. (2009) Dopamine–glutamate abnormalities in the frontal cortex associated with the catechol-O-methyltransferase (COMT) in schizophrenia. Brain Research 1269, pages 166-175.
Crossref
Susan J. Sara. (2009) The locus coeruleus and noradrenergic modulation of cognition. Nature Reviews Neuroscience 10:3, pages 211-223.
Crossref
Florence Loiseau & Mark J. Millan. (2009) Blockade of dopamine D3 receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: Similar actions of D1 receptor agonists, but not of D2 antagonists. European Neuropsychopharmacology 19:1, pages 23-33.
Crossref
Gianluigi Tanda, Amy H. Newman & Jonathan L. Katz. 2009. Contemporary Aspects of Biomedical Research - Drug Discovery. Contemporary Aspects of Biomedical Research - Drug Discovery 253 289 .
Mikhail V. Pletnikov. 2009. Genetic Models of Schizophrenia. Genetic Models of Schizophrenia 35 47 .
Sarah J. Bailey & Peter J. McCaffery. 2009. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes 171 189 .
Sylco S. Hoppenbrouwers, Dennis J.L.G. Schutter, Paul B. Fitzgerald, Robert Chen & Zafiris J. Daskalakis. (2008) The role of the cerebellum in the pathophysiology and treatment of neuropsychiatric disorders: A review. Brain Research Reviews 59:1, pages 185-200.
Crossref
Jeffrey A. Lieberman, Frank P. Bymaster, Herbert Y. Meltzer, Ariel Y. Deutch, Gary E. Duncan, Christine E. Marx, June R. Aprille, Donard S. Dwyer, Xin-Min Li, Sahebarao P. Mahadik, Ronald S. Duman, Joseph H. Porter, Josephine S. Modica-Napolitano, Samuel S. Newton & John G. Csernansky. (2008) Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection. Pharmacological Reviews 60:3, pages 358-403.
Crossref
Marzia Martina & Richard Bergeron. (2008) D1 and D4 dopaminergic receptor interplay mediates coincident G protein-independent and dependent regulation of glutamate NMDA receptors in the lateral amygdala. Journal of Neurochemistry 106:6, pages 2421-2435.
Crossref
Francesca R. Buttarelli, Clelia Pellicano & Francesco E. Pontieri. (2008) Neuropharmacology and behavior in planarians: Translations to mammals. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 147:4, pages 399-408.
Crossref
Florian Schlagenhauf, Georg Juckel, Michael Koslowski, Thorsten Kahnt, Brian Knutson, Theresa Dembler, Thorsten Kienast, Jürgen Gallinat, Jana Wrase & Andreas Heinz. (2007) Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology 196:4, pages 673-684.
Crossref
Rima Kaddurah-Daouk, Jair C. Soares & Marlon P. Quinones. 2009. Biomarkers for Psychiatric Disorders. Biomarkers for Psychiatric Disorders 129 162 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.